Related references
Note: Only part of the references are listed.Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
Gerardo Aguilar et al.
CRITICAL CARE (2019)
Clinical experience with ceftolozane/tazobactam in patients with serious infections due to resistant Pseudomonas aeruginosa
Marc Xipell et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
Wesley D. Oliver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration
Joseph L. Kuti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Extracorporeal Elimination of Piperacillin/Tazobactam during Molecular Adsorbent Recirculating System Therapy
Heather A. Personett et al.
PHARMACOTHERAPY (2015)
Share Paper
